Please be advised that procedures connected with admission of Bioceltix S.A. shares to stock exchange trading are currently being finalized. ...
Read full
Łukasz Bzdzion, President of the Management Board, participated in the XXX Economic Forum in Karpacz on behalf of Bioceltix. The second day of ...
Read full
We made the next important step on the way to the registration of our drug candidates in the European Medicines Agency. The next phase of ...
Read fullIn connection with the issue of series G shares, on April 23, 2021, an increase in the share capital was registered. All formalities related to ...
Read full
We would like to inform you that Dom Maklerski Banku Ochrony Środowiska S.A. has joined the group of consortium members accepting subscriptions ...
Read full
On 02/03/2021 there was an investor chat with our participation. We invite you to watch the chat here: ...
Read fullPuls Biznesu about our plans: Bioceltix announces that it will soon debut on NewConnect – the company has recently completed the pre-IPO round. So far, the company has obtained a total of approx. PLN 20 million in financing for the development of a still innovative method of treating pets ...
ArticleForbes about Polish start-ups in the coronavirus crisis: “The year 2020 was a big challenge for companies, individual sectors of the economy and probably all of us. In the coming weeks and months of 2021 it will be similar. The condition of start-ups is no exception here. it is easier and ...
ArticleAccording to the „Investors’ Zone”, an interesting year is being prepared on the stock exchange: “This year, an exceptionally large group of companies is choosing NewConnect. As many as 63 companies declared their willingness to enter the alternative market, and several more in the ...
ArticleGazeta Wrocławska wrote about us: “Bioceltix is working on innovative biological medicines used in the treatment of common autoimmune and inflammatory diseases in companion animals. The company from Wrocław has something to fight for. This is indicated by the numbers on the global drug ...
ArticleWe create at Bioceltix veterinary biological medicines, and in 2020 we announced plans for a stock exchange debut and we obtained a permit from the Main Pharmaceutical Inspector to manufacture veterinary biological drugs. Despite the pandemic, we continue our projects without downtime. You can ...
Article
